Document is current
Any future updates will be listed below
-
Authors
Nutt, David J.
Lingford-Hughes, Anne
Erritzoe, David
Stokes, Paul R. A.
- License Information
-
More Information
Article History
First Online: 15 April 2015
Competing interests
: D.J.N. has received speaker's fees, or travel or grant support from companies with an interest in the treatment of addiction: RB pharmaceuticals, Lundbeck, GlaxoSmithKline, Pfizer, D&A Pharma and Nalpharm. A.L.-H. has received speaker's fees and grant support from Lundbeck and GlaxoSmithKline. D.E. has received grant support from GlaxoSmithKline. P.R.A.S. declares no competing interests.
